WHO prequalifies Serum Institute of India’s quadrivalent HPV vaccine, CERVAVAC | Explained

The development is significant for India as well as the global effort to prevent cervical cancer
Read the full story on The Hindu Opens thehindu.com in a new tab
Advertisement
CallZenixAI Voice Bot, Dialer & IVR SolutionsCloud dialer and contact-center software for your teamKnow more
This is a short summary of a story published by The Hindu, shown with a link to the original. The full story, photo and reporting belong to The Hindu.









